This variability in the degree of brain damage following systemic KA administration is in agreement with previous studies [17], [55] and confirms previous observations that GalR1 gene disruption renders the brain more susceptible to status epilepticus-induced brain damage. Here, GALR1 is linked to status epilepticus.